Adam Gabriele, Ousingsawat Jiraporn, Schreiber Rainer, Kunzelmann Karl
Institut für Physiologie, Universität Regensburg, Universitätsstrasse 31, 93053, Regensburg, Germany.
Pflugers Arch. 2005 Feb;449(5):470-8. doi: 10.1007/s00424-004-1356-4. Epub 2004 Oct 29.
In the lungs of cystic fibrosis (CF) patients, mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) lead to defective Cl- secretion and hyperabsorption of electrolytes. This may be a an important cause for the defective mucociliary clearance in CF lungs. Previous studies have suggested that inhibition of ENaC during activation of CFTR or by purinergic stimulation could be related to an increase in the intracellular [Cl-]i. This was examined in the present study using cultured mouse M1 collecting duct cells transfected with the chloride-sensitive enhanced yellow fluorescent protein YFP(V163S). Calibration experiments showed a linear decrease of YFP fluorescence intensity with increasing [Cl-]i (0-100 mM). Activation of CFTR by isobutyl-1-methylxanthine (IBMX, 100 microM) and forskolin (2 microM) increased [Cl-]i by 9.6+/-1.5 mM (n=35). Similarly, ATP (100 microM) increased [Cl-]i transiently by 9.5+/-2.2 mM (n=17). The increase in [Cl-]i was reduced by the Na+/K+/2 Cl- -cortransporter-1 (NKCC1) blocker azosemide (100 microM), the CFTR blocker SP-303 (50 microM), the blocker of Ca2+-activated Cl- channels DIDS (100 microM) or the ENaC blocker amiloride (10 microM). Changes in YFP(V163S) fluorescence were not due to changes in cell volume or intracellular pH. The present data thus demonstrate an increase in [Cl-]i following stimulation with secretagogues, which could participate in the inhibition of ENaC.
在囊性纤维化(CF)患者的肺部,囊性纤维化跨膜传导调节因子(CFTR)的突变导致氯离子分泌缺陷和电解质过度吸收。这可能是CF肺部黏液纤毛清除功能缺陷的一个重要原因。先前的研究表明,在CFTR激活过程中或通过嘌呤能刺激抑制上皮钠通道(ENaC)可能与细胞内氯离子浓度([Cl-]i)升高有关。本研究使用转染了氯离子敏感型增强型黄色荧光蛋白YFP(V163S)的培养小鼠M1集合管细胞对此进行了检测。校准实验表明,随着[Cl-]i升高(0 - 100 mM),YFP荧光强度呈线性下降。用异丁基-1-甲基黄嘌呤(IBMX,100 μM)和福斯可林(2 μM)激活CFTR使[Cl-]i升高了9.6±1.5 mM(n = 35)。同样,ATP(100 μM)使[Cl-]i短暂升高了9.5±2.2 mM(n = 17)。[Cl-]i的升高被钠钾氯共转运体-1(NKCC1)阻断剂阿佐塞米(100 μM)、CFTR阻断剂SP - 303(50 μM)、钙激活氯离子通道阻断剂DIDS(100 μM)或ENaC阻断剂阿米洛利(10 μM)所降低。YFP(V163S)荧光的变化并非由于细胞体积或细胞内pH值的改变。因此,本研究数据表明,促分泌剂刺激后[Cl-]i升高,这可能参与了对ENaC的抑制。